StockData
CG Oncology, Inc. logo

CG Oncology, Inc. (CGON) stock

CGONNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$78.94−5.84 (-6.89%)

Close on Nov 17, 2026Market cap $7.00BP/E –Yield –

CG Oncology price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

CG Oncology's price to book ratio was 6.2× on Nov 11, 2026, against 5.1× a year earlier. Over the last 3 years it ranged from 2.5× to 7.3×, with a median of 4.6×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20266.2×+1.5
2025Dec 31, 20254.7×+1.1
2024Dec 31, 20243.6×–

More CG Oncology figures

See a number that looks wrong?